Skip to main
TFX
TFX logo

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 17%
Buy 33%
Hold 46%
Sell 4%
Strong Sell 0%

Bulls say

Teleflex has demonstrated a robust potential for growth, with expected sales growth at least around 6% off a nearly $1 billion base, driven by the strategic performance of its interventional business. Key upside drivers include anticipated revenue growth, margin expansion, and further accretive acquisitions, aligning with historical performance trends that supported sustained growth prospects. Additionally, the company’s focus on higher growth products and successful new product launches suggests that Teleflex could achieve organic revenue growth of 4-6%, leading to above-consensus earnings growth in the medium term.

Bears say

Teleflex's stock outlook appears negative due to significantly lower-than-expected revenue growth guidance of 1.0-2.0% for 2025, which falls short of the market's expectation of 4.5%. The company also experienced a revenue shortfall in its 4Q24 results, with GAAP revenue growth projected between -0.4% and 0.7%, indicating challenges in multiple segments, particularly in UroLift and OEM. Furthermore, the announced acquisition of Biotronik's Vascular Intervention business for approximately $820 million and the company’s planned break-up raise concerns about execution risks and potential dilution of earnings per share.

Teleflex (TFX) has been analyzed by 24 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 46% suggest Holding, 4% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 24 analysts, Teleflex (TFX) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $255.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $255.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.